The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity.
The capacity of allosensitized thymus-derived lymphocytes to destroy target cells bearing donor alloantigens is modulated by the cellular levels of cyclic AMP and cyclic GMP. Increases in the cyclic AMP levels of attacking lymphocytes by stimulation with prostaglandin E(1), isoproterenol, and cholera toxin inhibit lymphocyte-mediated cytotoxicity; whereas, depletion of cyclic AMP with imidazole enhances cytotoxicity. The augmentation of cytotoxicity produced by cholinergic stimulation with carbamylcholine is not associated with alterations in cyclic AMP levels and is duplicated by 8-bromo-cyclic GMP. The effects of activators of adenylate cyclase, cholinomimetic agents, and 8-bromocyclic GMP are upon the attacking and not the target cells and occur at the time of initial interaction of attacking and target cells. Indeed, the level of cyclic nucleotide (cyclic AMP and cyclic GMP) at the time of initial cell-to-cell interaction determines the extent of cytotoxicity.
D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002771:Cholera / Q000276:immunology; D000242:Cyclic AMP / Q000502:physiology*; D006152:Cyclic GMP / Q000502:physiology*; D003601:Cytotoxicity Tests, Immunologic; D006084:Graft Rejection; D007093:Imidazoles / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008212:Lymphocyte Depletion; D011453:Prostaglandins / Q000494:pharmacology; D051381:Rats; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D014118:Toxins, Biological / Q000494:pharmacology
D007093:Imidazoles; D011453:Prostaglandins; D014118:Toxins, Biological; D002217:Carbachol; D000242:Cyclic AMP; D006152:Cyclic GMP; D007545:Isoproterenol